News and Announcements
Credi Processes Over $70 m in Loans in 10 months
- Published January 16, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
Launched March 2018 to provide loan management for P2P loan between friends, family and colleagues. By year-end:
- Over 2,000 users
- 10,000 unique visitors a month to Credi.com
- Over $ 70 m of loans on the platform
- Users in 10 countries
- Partner program planned for 2018
- Oversubscribed seed round of $ 500 K completed
- Advisory board and executive team strengthened
- Award-winning Fintech
2017 saw Credi establish itself as the global leader in P2P loan management between friends family colleagues, with an expanding user base of thousands of users across the globe using Credi to manage their lending. Loans for diverse uses such as cars, property, personal finance, debt consolidation, start up funding amounted to millions of dollars – with individuals establishing , documenting and managing these transactions between themselves.
2018 will see a global rollout, a partner program , the addition of numerous market specific loan types including registration of security interest , a credi wallet for micro transactions , bank transaction automation and multi language documentation.
About Credi Pty Ltd
If you’ve ever loaned your children money you are officially a branch manager of “The Bank of Mum and Dad”. You are also a part of one of fast-growing sectors of the Australian economy. Credi.com was born out of the pressing need to document loans between family members, friends and businesses. It removes the stress, the embarrassment and the risk of legal action, formalising a loan within minutes and without a scrap of costly, time-consuming paperwork.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
